Plasma Cell Disorder
9 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Study to Assess Safety of HDP-101 in Patients With Relapsed Refractory Multiple Myeloma (NCT04879043) | Heidelberg Pharma AG | 2022-02-07 |
| Evaluation of the Plasma Cell Disorders Panel on the BD FACSLyric™ Flow Cytometer (NCT05032339) | Becton, Dickinson and Company | 2021-05-04 |
| Haploidentical Allogeneic Peripheral Blood Transplantation: Examining Checkpoint Immune Regulators' Expression (NCT03480360) | Dartmouth-Hitchcock Medical Center | 2018-03-28 |
| Novel Support Options in Autologous Stem Cell Transplant for Multiple Myeloma (NCT02274519) | Mayo Clinic | 2015-02-01 |
| Investigation of the Enhancement of Response to Hepatitis B Vaccine by Lenalidomide in Plasma Cell Dyscrasias (NCT02041325) | Boston VA Research Institute, Inc. | 2005-04-01 |
Track Plasma Cell Disorder automatically
Every clearance here is in the API, with alerts when new ones post.